CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart Association Switching P2Y12-receptor inhibitors in patients with coronary artery disease Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock Dynamic Myocardial Ultrasound Localization Angiography Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia
|<<... 22 23 24 25 26 27 28 29 >>|

ConsensusApril 2020

JOURNAL：JACC Article Link

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

E Mahmud, HL Dauerman, FGP Welt et al. Keywords: emergency medical system; COVID-19; fibrinolysis; PCI; STEMI

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top